Blood pressure pattern among blood donors exposed to SARS-CoV-2 in Luanda, Angola: A retrospective study.
ABO/Rh blood groups
Angola
Luanda
SARS‐CoV‐2
hypertension
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
24
02
2023
revised:
25
07
2023
accepted:
03
08
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
SARS-CoV-2 infection is a public health concern. Several aspects related to the pattern of infection remain unclear. This study aimed to investigate the blood pressure pattern among blood donors exposed to SARS-CoV-2 in Luanda, Angola, a sub-Saharan African country. We performed a retrospective analysis containing 343 blood donors from December 2019 to September 2020. Parametric tests compared means while The mean age of blood donors was 32.2 ± 8.81 years (ranging from 18 to 61 years) and 93% of the men's gender. Overall, 4.7% of the studied population had been exposed to SARS-CoV-2. High blood pressure prevalence increased from unexposed to exposed SARS-CoV-2 (6.7%-18.8%, We showed important variations in blood pressure indices of the Angolan population exposed to SARS-CoV-2. Older age and non-O blood groups appear to be important biological factors for SARS-CoV-2 infection, as well as the risk of developing cardiovascular disease after or during SARS-CoV-2 exposure. Further studies assessing the impact on cardiovascular functions with ongoing or long-term SARS-CoV-2 exposure in individuals from resource-limited countries should be considered.
Sections du résumé
Background and Aims
UNASSIGNED
SARS-CoV-2 infection is a public health concern. Several aspects related to the pattern of infection remain unclear. This study aimed to investigate the blood pressure pattern among blood donors exposed to SARS-CoV-2 in Luanda, Angola, a sub-Saharan African country.
Methods
UNASSIGNED
We performed a retrospective analysis containing 343 blood donors from December 2019 to September 2020. Parametric tests compared means while
Results
UNASSIGNED
The mean age of blood donors was 32.2 ± 8.81 years (ranging from 18 to 61 years) and 93% of the men's gender. Overall, 4.7% of the studied population had been exposed to SARS-CoV-2. High blood pressure prevalence increased from unexposed to exposed SARS-CoV-2 (6.7%-18.8%,
Conclusion
UNASSIGNED
We showed important variations in blood pressure indices of the Angolan population exposed to SARS-CoV-2. Older age and non-O blood groups appear to be important biological factors for SARS-CoV-2 infection, as well as the risk of developing cardiovascular disease after or during SARS-CoV-2 exposure. Further studies assessing the impact on cardiovascular functions with ongoing or long-term SARS-CoV-2 exposure in individuals from resource-limited countries should be considered.
Identifiants
pubmed: 37599663
doi: 10.1002/hsr2.1498
pii: HSR21498
pmc: PMC10432586
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1498Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Am J Hypertens. 2020 Apr 29;33(5):373-374
pubmed: 32251498
Am J Blood Res. 2021 Feb 15;11(1):53-58
pubmed: 33796389
J Hypertens. 2007 Sep;25(9):1751-62
pubmed: 17762635
Health Sci Rep. 2023 Jun 07;6(6):e1300
pubmed: 37305153
High Blood Press Cardiovasc Prev. 2022 Mar;29(2):115-123
pubmed: 35184271
BMC Infect Dis. 2021 Nov 2;21(1):1131
pubmed: 34727874
Iran J Pathol. 2020 Summer;15(3):156-160
pubmed: 32754209
PLoS Med. 2004 Oct;1(1):e27
pubmed: 15526049
BMJ Open. 2022 Sep 13;12(9):e061752
pubmed: 36100306
Blut. 1973 Nov;27(5):322-35
pubmed: 4202184
Circ Res. 2021 Apr 2;128(7):808-826
pubmed: 33793340
Viruses. 2020 May 26;12(6):
pubmed: 32466458
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Pak J Med Sci. 2021 Jan-Feb;37(1):4-8
pubmed: 33437242
Glob Health Promot. 2021 Jun;28(2):83-86
pubmed: 33579179
Adv Exp Med Biol. 2021;1321:147-162
pubmed: 33656721
Health Sci Rep. 2021 May 06;4(2):e280
pubmed: 33977162
Nat Commun. 2020 Nov 13;11(1):5761
pubmed: 33188185
PLoS Med. 2022 Sep 8;19(9):e1004093
pubmed: 36074784
N Engl J Med. 1996 Jan 4;334(1):13-8
pubmed: 7494564
Int J Environ Res Public Health. 2021 Jan 01;18(1):
pubmed: 33401440
Biomedicines. 2022 Aug 26;10(9):
pubmed: 36140191
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
Ann Intern Med. 2021 Mar;174(3):308-315
pubmed: 33226859
J Gerontol A Biol Sci Med Sci. 1997 May;52(3):M177-83
pubmed: 9158560
Turk J Med Sci. 2020 Apr 17;50(SI-1):563-570
pubmed: 32299206
Am J Hypertens. 2021 Apr 2;34(3):282-290
pubmed: 33386395
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Clin Res Cardiol. 2020 Dec;109(12):1460-1468
pubmed: 32809116
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
PLoS One. 2021 Mar 25;16(3):e0249249
pubmed: 33765102
Blood Adv. 2020 Oct 27;4(20):4981-4989
pubmed: 33057633
Antimicrob Steward Healthc Epidemiol. 2021 Dec 07;1(1):e60
pubmed: 36168505